Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 CMX-020
1.2.3 CA-016
1.2.4 DD-04107
1.2.5 Others
1.3 Market by Application
1.3.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Growth Rate by Application: 2018 VS 2024 VS 2034
1.3.2 Ophthalmology
1.3.3 Immunology
1.3.4 Muscle Spasm
1.3.5 Pruritus
1.3.6 Abdominal Pain
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2018-2034)
2.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size across Key Geographies Worldwide: 2018 VS 2024 VS 2034
2.3 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (2018-2023)
2.4 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Forecast by Region (2024-2034)
2.5 Global Top 10 Transient Receptor Potential Cation Channel Subfamily V Member 1 Countries Ranking by Market Size
3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Competitive by Company
3.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Players
3.1.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Players (2018-2023)
3.1.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Players (2018-2023)
3.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue
3.4 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Concentration Ratio
3.4.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue in 2024
3.5 Global Key Players of Transient Receptor Potential Cation Channel Subfamily V Member 1 Head office and Area Served
3.6 Global Key Players of Transient Receptor Potential Cation Channel Subfamily V Member 1, Product and Application
3.7 Global Key Players of Transient Receptor Potential Cation Channel Subfamily V Member 1, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Breakdown Data by Type
4.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Historic Revenue by Type (2018-2023)
4.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecasted Revenue by Type (2024-2034)
5 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Breakdown Data by Application
5.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Historic Market Size by Application (2018-2023)
5.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Company (2021-2023)
6.2 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2018-2034)
6.3 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2018-2034)
6.4 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2018-2034)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Company (2021-2023)
7.2 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2018-2034)
7.3 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2018-2034)
7.4 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2018-2034)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Company (2021-2023)
8.2 Asia Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2018-2034)
8.3 Asia Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2018-2034)
8.4 Asia Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Region (2018-2034)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Company (2021-2023)
9.2 Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2018-2034)
9.3 Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2018-2034)
9.4 Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2018-2034)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Company (2021-2023)
10.2 Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2018-2034)
10.3 Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2018-2034)
10.4 Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2018-2034)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Amgen Inc
11.1.1 Amgen Inc Company Details
11.1.2 Amgen Inc Business Overview
11.1.3 Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Products and Services
11.1.4 Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023)
11.1.5 Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 SWOT Analysis
11.1.6 Amgen Inc Recent Development
11.2 Amorepacific Corp
11.2.1 Amorepacific Corp Company Details
11.2.2 Amorepacific Corp Business Overview
11.2.3 Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Products and Services
11.2.4 Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023)
11.2.5 Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 SWOT Analysis
11.2.6 Amorepacific Corp Recent Development
11.3 BCN Peptides SA
11.3.1 BCN Peptides SA Company Details
11.3.2 BCN Peptides SA Business Overview
11.3.3 BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Products and Services
11.3.4 BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023)
11.3.5 BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 SWOT Analysis
11.3.6 BCN Peptides SA Recent Development
11.4 Centrexion Therapeutics Corp
11.4.1 Centrexion Therapeutics Corp Company Details
11.4.2 Centrexion Therapeutics Corp Business Overview
11.4.3 Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Products and Services
11.4.4 Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023)
11.4.5 Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 SWOT Analysis
11.4.6 Centrexion Therapeutics Corp Recent Development
11.5 Daewoong Pharmaceutical Co Ltd
11.5.1 Daewoong Pharmaceutical Co Ltd Company Details
11.5.2 Daewoong Pharmaceutical Co Ltd Business Overview
11.5.3 Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Products and Services
11.5.4 Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023)
11.5.5 Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 SWOT Analysis
11.5.6 Daewoong Pharmaceutical Co Ltd Recent Development
11.6 DoNatur GmbH
11.6.1 DoNatur GmbH Company Details
11.6.2 DoNatur GmbH Business Overview
11.6.3 DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Products and Services
11.6.4 DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023)
11.6.5 DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 SWOT Analysis
11.6.6 DoNatur GmbH Recent Development
11.7 Flex Pharma Inc
11.7.1 Flex Pharma Inc Company Details
11.7.2 Flex Pharma Inc Business Overview
11.7.3 Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Products and Services
11.7.4 Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023)
11.7.5 Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 SWOT Analysis
11.7.6 Flex Pharma Inc Recent Development
11.8 Grunenthal GmbH
11.8.1 Grunenthal GmbH Company Details
11.8.2 Grunenthal GmbH Business Overview
11.8.3 Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Products and Services
11.8.4 Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023)
11.8.5 Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 SWOT Analysis
11.8.6 Grunenthal GmbH Recent Development
11.9 Kyowa Hakko Kirin Co Ltd
11.9.1 Kyowa Hakko Kirin Co Ltd Company Details
11.9.2 Kyowa Hakko Kirin Co Ltd Business Overview
11.9.3 Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Products and Services
11.9.4 Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023)
11.9.5 Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 SWOT Analysis
11.9.6 Kyowa Hakko Kirin Co Ltd Recent Development
11.10 Medifron DBT Co Ltd
11.10.1 Medifron DBT Co Ltd Company Details
11.10.2 Medifron DBT Co Ltd Business Overview
11.10.3 Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Products and Services
11.10.4 Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023)
11.10.5 Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 SWOT Analysis
11.10.6 Medifron DBT Co Ltd Recent Development
11.11 Neurim Pharmaceuticals Ltd
11.11.1 Neurim Pharmaceuticals Ltd Company Details
11.11.2 Neurim Pharmaceuticals Ltd Business Overview
11.11.3 Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Products and Services
11.11.4 Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023)
11.11.5 Neurim Pharmaceuticals Ltd Recent Development
11.12 Pila Pharma AB
11.12.1 Pila Pharma AB Company Details
11.12.2 Pila Pharma AB Business Overview
11.12.3 Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Products and Services
11.12.4 Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023)
11.12.5 Pila Pharma AB Recent Development
11.13 Sylentis SAU
11.13.1 Sylentis SAU Company Details
11.13.2 Sylentis SAU Business Overview
11.13.3 Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Products and Services
11.13.4 Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023)
11.13.5 Sylentis SAU Recent Development
11.14 Toray Industries Inc
11.14.1 Toray Industries Inc Company Details
11.14.2 Toray Industries Inc Business Overview
11.14.3 Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Products and Services
11.14.4 Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023)
11.14.5 Toray Industries Inc Recent Development
11.15 Vitality Biopharma Inc
11.15.1 Vitality Biopharma Inc Company Details
11.15.2 Vitality Biopharma Inc Business Overview
11.15.3 Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Products and Services
11.15.4 Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023)
11.15.5 Vitality Biopharma Inc Recent Development
12 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Dynamics
12.1 Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Trends
12.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Drivers
12.3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Challenges
12.4 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details

List of Figure

List of Tables
Table 1. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2024 VS 2034
Table 2. Key Players of CMX-020
Table 3. Key Players of CA-016
Table 4. Key Players of DD-04107
Table 5. Key Players of Others
Table 6. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate by Application (US$ Million), 2018 VS 2024 VS 2034
Table 7. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2024 VS 2034
Table 8. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Region (2018-2023) & (US$ Million)
Table 9. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Forecast by Region (2024-2034) & (US$ Million)
Table 10. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size of Top 10 Countries, 2018 VS 2024 VS 2034, (US$ Million)
Table 11. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Players (2018-2023) & (US$ Million)
Table 12. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Players (2018-2023)
Table 13. Global Top Transient Receptor Potential Cation Channel Subfamily V Member 1 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 as of 2024)
Table 14. Ranking of Global Top Transient Receptor Potential Cation Channel Subfamily V Member 1 Companies by Revenue (US$ Million) in 2024
Table 15. Global 5 Largest Players Market Share by Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (CR5 and HHI) & (2018-2023)
Table 16. Global Key Players of Transient Receptor Potential Cation Channel Subfamily V Member 1, Headquarters and Area Served
Table 17. Global Key Players of Transient Receptor Potential Cation Channel Subfamily V Member 1, Product and Application
Table 18. Global Key Players of Transient Receptor Potential Cation Channel Subfamily V Member 1, Date of Enter into This Industry
Table 19. Mergers & Acquisitions, Expansion Plans
Table 20. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2018-2023) & (US$ Million)
Table 21. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Type (2018-2023)
Table 22. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 23. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Type (2024-2034)
Table 24. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2018-2023) & (US$ Million)
Table 25. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Application (2018-2023)
Table 26. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 27. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Application (2024-2034)
Table 28. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Company (2021-2023) & (US$ Million)
Table 29. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2018-2023) & (US$ Million)
Table 30. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2024-2034) & (US$ Million)
Table 31. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2018-2023) & (US$ Million)
Table 32. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2024-2034) & (US$ Million)
Table 33. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 34. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2018-2023) & (US$ Million)
Table 35. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2024-2034) & (US$ Million)
Table 36. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Company (2021-2023) & (US$ Million)
Table 37. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2018-2023) & (US$ Million)
Table 38. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2024-2034) & (US$ Million)
Table 39. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2018-2023) & (US$ Million)
Table 40. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2024-2034) & (US$ Million)
Table 41. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 42. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2018-2023) & (US$ Million)
Table 43. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2024-2034) & (US$ Million)
Table 44. Asia Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Company (2021-2023) & (US$ Million)
Table 45. Asia Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2018-2023) & (US$ Million)
Table 46. Asia Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2024-2034) & (US$ Million)
Table 47. Asia Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2018-2023) & (US$ Million)
Table 48. Asia Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2024-2034) & (US$ Million)
Table 49. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 50. Asia Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Region (2018-2023) & (US$ Million)
Table 51. Asia Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Region (2024-2034) & (US$ Million)
Table 52. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Company (2021-2023) & (US$ Million)
Table 53. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2018-2023) & (US$ Million)
Table 54. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2024-2034) & (US$ Million)
Table 55. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2018-2023) & (US$ Million)
Table 56. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2024-2034) & (US$ Million)
Table 57. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 58. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2018-2023) & (US$ Million)
Table 59. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2024-2034) & (US$ Million)
Table 60. Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Company (2021-2023) & (US$ Million)
Table 61. Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2018-2023) & (US$ Million)
Table 62. Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2024-2034) & (US$ Million)
Table 63. Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2018-2023) & (US$ Million)
Table 64. Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2024-2034) & (US$ Million)
Table 65. Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 66. Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2018-2023) & (US$ Million)
Table 67. Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2024-2034) & (US$ Million)
Table 68. Amgen Inc Company Details
Table 69. Amgen Inc Business Overview
Table 70. Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Services
Table 71. Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023) & (US$ Million)
Table 72. Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 SWOT Analysis
Table 73. Amgen Inc Recent Development
Table 74. Amorepacific Corp Company Details
Table 75. Amorepacific Corp Business Overview
Table 76. Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Services
Table 77. Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023) & (US$ Million)
Table 78. Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 SWOT Analysis
Table 79. Amorepacific Corp Recent Development
Table 80. BCN Peptides SA Company Details
Table 81. BCN Peptides SA Business Overview
Table 82. BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Services
Table 83. BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023) & (US$ Million)
Table 84. BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 SWOT Analysis
Table 85. BCN Peptides SA Recent Development
Table 86. Centrexion Therapeutics Corp Company Details
Table 87. Centrexion Therapeutics Corp Business Overview
Table 88. Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Services
Table 89. Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023) & (US$ Million)
Table 90. Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 SWOT Analysis
Table 91. Centrexion Therapeutics Corp Recent Development
Table 92. Daewoong Pharmaceutical Co Ltd Company Details
Table 93. Daewoong Pharmaceutical Co Ltd Business Overview
Table 94. Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Services
Table 95. Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023) & (US$ Million)
Table 96. Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 SWOT Analysis
Table 97. Daewoong Pharmaceutical Co Ltd Recent Development
Table 98. DoNatur GmbH Company Details
Table 99. DoNatur GmbH Business Overview
Table 100. DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Services
Table 101. DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023) & (US$ Million)
Table 102. DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 SWOT Analysis
Table 103. DoNatur GmbH Recent Development
Table 104. Flex Pharma Inc Company Details
Table 105. Flex Pharma Inc Business Overview
Table 106. Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Services
Table 107. Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023) & (US$ Million)
Table 108. Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 SWOT Analysis
Table 109. Flex Pharma Inc Recent Development
Table 110. Grunenthal GmbH Company Details
Table 111. Grunenthal GmbH Business Overview
Table 112. Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Services
Table 113. Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023) & (US$ Million)
Table 114. Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 SWOT Analysis
Table 115. Grunenthal GmbH Recent Development
Table 116. Kyowa Hakko Kirin Co Ltd Company Details
Table 117. Kyowa Hakko Kirin Co Ltd Business Overview
Table 118. Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Services
Table 119. Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023) & (US$ Million)
Table 120. Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 SWOT Analysis
Table 121. Kyowa Hakko Kirin Co Ltd Recent Development
Table 122. Medifron DBT Co Ltd Company Details
Table 123. Medifron DBT Co Ltd Business Overview
Table 124. Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Services
Table 125. Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023) & (US$ Million)
Table 126. Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 SWOT Analysis
Table 127. Medifron DBT Co Ltd Recent Development
Table 128. Neurim Pharmaceuticals Ltd Company Details
Table 129. Neurim Pharmaceuticals Ltd Business Overview
Table 130. Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Services
Table 131. Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023) & (US$ Million)
Table 132. Neurim Pharmaceuticals Ltd Recent Development
Table 133. Pila Pharma AB Company Details
Table 134. Pila Pharma AB Business Overview
Table 135. Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Services
Table 136. Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023) & (US$ Million)
Table 137. Pila Pharma AB Recent Development
Table 138. Sylentis SAU Company Details
Table 139. Sylentis SAU Business Overview
Table 140. Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Services
Table 141. Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023) & (US$ Million)
Table 142. Sylentis SAU Recent Development
Table 143. Toray Industries Inc Company Details
Table 144. Toray Industries Inc Business Overview
Table 145. Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Services
Table 146. Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023) & (US$ Million)
Table 147. Toray Industries Inc Recent Development
Table 148. Vitality Biopharma Inc Company Details
Table 149. Vitality Biopharma Inc Business Overview
Table 150. Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Services
Table 151. Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023) & (US$ Million)
Table 152. Vitality Biopharma Inc Recent Development
Table 153. Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Trends
Table 154. Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Drivers
Table 155. Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Challenges
Table 156. Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Restraints
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Picture
Figure 2. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (US$ Million): 2018 VS 2024 VS 2034
Figure 3. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Type: 2024 VS 2034
Figure 4. CMX-020 Features
Figure 5. CA-016 Features
Figure 6. DD-04107 Features
Figure 7. Others Features
Figure 8. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (US$ Million): 2018 VS 2024 VS 2034
Figure 9. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Application: 2024 VS 2034
Figure 10. Ophthalmology
Figure 11. Immunology
Figure 12. Muscle Spasm
Figure 13. Pruritus
Figure 14. Abdominal Pain
Figure 15. Others
Figure 16. Transient Receptor Potential Cation Channel Subfamily V Member 1 Report Years Considered
Figure 17. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 18. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2018-2034 (US$ Million)
Figure 19. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Region: 2024 VS 2034
Figure 20. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Region in 2018 VS 2024
Figure 21. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share Forecast by Region (2024-2034)
Figure 22. Global Top 10 Transient Receptor Potential Cation Channel Subfamily V Member 1 Countries Ranking by Market Size (US$ Million) in 2024
Figure 23. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size of Top 10 Countries, 2018 VS 2024 VS 2034, (US$ Million)
Figure 24. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Players in 2024
Figure 25. Global Top Transient Receptor Potential Cation Channel Subfamily V Member 1 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 as of 2024)
Figure 26. The Top 10 and 5 Players Market Share by Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue in 2024
Figure 27. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Company in 2024
Figure 28. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Type (2018-2034)
Figure 29. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Application (2018-2034)
Figure 30. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Country (2018-2034)
Figure 31. U.S. Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (2018-2034) & (US$ Million)
Figure 32. Canada Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (2018-2034) & (US$ Million)
Figure 33. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Company in 2024
Figure 34. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Type (2018-2034)
Figure 35. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Application (2018-2034)
Figure 36. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Country (2018-2034)
Figure 37. Germany Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (2018-2034) & (US$ Million)
Figure 38. France Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (2018-2034) & (US$ Million)
Figure 39. U.K. Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (2018-2034) & (US$ Million)
Figure 40. Italy Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (2018-2034) & (US$ Million)
Figure 41. Russia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (2018-2034) & (US$ Million)
Figure 42. Asia Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Company in 2024
Figure 43. Asia Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Type (2018-2034)
Figure 44. Asia Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Application (2018-2034)
Figure 45. Asia Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Region (2018-2034)
Figure 46. China Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (2018-2034) & (US$ Million)
Figure 47. Japan Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (2018-2034) & (US$ Million)
Figure 48. South Korea Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (2018-2034) & (US$ Million)
Figure 49. India Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (2018-2034) & (US$ Million)
Figure 50. Australia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (2018-2034) & (US$ Million)
Figure 51. Taiwan Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (2018-2034) & (US$ Million)
Figure 52. Indonesia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (2018-2034) & (US$ Million)
Figure 53. Thailand Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (2018-2034) & (US$ Million)
Figure 54. Malaysia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (2018-2034) & (US$ Million)
Figure 55. Philippines Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (2018-2034) & (US$ Million)
Figure 56. Vietnam Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (2018-2034) & (US$ Million)
Figure 57. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Company in 2024
Figure 58. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Type (2018-2034)
Figure 59. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Application (2018-2034)
Figure 60. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Country (2018-2034)
Figure 61. Mexico Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (2018-2034) & (US$ Million)
Figure 62. Brazil Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (2018-2034) & (US$ Million)
Figure 63. Argentina Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (2018-2034) & (US$ Million)
Figure 64. Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Company in 2024
Figure 65. Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Type (2018-2034)
Figure 66. Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Application (2018-2034)
Figure 67. Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Country (2018-2034)
Figure 68. Turkey Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (2018-2034) & (US$ Million)
Figure 69. Saudi Arabia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (2018-2034) & (US$ Million)
Figure 70. UAE Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (2018-2034) & (US$ Million)
Figure 71. Amgen Inc Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023)
Figure 72. Amorepacific Corp Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023)
Figure 73. BCN Peptides SA Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023)
Figure 74. Centrexion Therapeutics Corp Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023)
Figure 75. Daewoong Pharmaceutical Co Ltd Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023)
Figure 76. DoNatur GmbH Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023)
Figure 77. Flex Pharma Inc Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023)
Figure 78. Grunenthal GmbH Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023)
Figure 79. Kyowa Hakko Kirin Co Ltd Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023)
Figure 80. Medifron DBT Co Ltd Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023)
Figure 81. Neurim Pharmaceuticals Ltd Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023)
Figure 82. Pila Pharma AB Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023)
Figure 83. Sylentis SAU Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023)
Figure 84. Toray Industries Inc Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023)
Figure 85. Vitality Biopharma Inc Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2018-2023)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed